Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Nitrogen containing other than solely as a nitrogen in an...
Reexamination Certificate
2005-07-07
2008-11-25
Badio, Barbara P (Department: 1612)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Nitrogen containing other than solely as a nitrogen in an...
C514S825000
Reexamination Certificate
active
07456220
ABSTRACT:
The invention relates to immunomodulatory compositions and related methods. The immunomodulatory compositions of a formula disclosed herein are useful for the prevention of sepsis and the treatment and prevention of diseases associated with inflammation and/or NOS.
REFERENCES:
patent: 4141973 (1979-02-01), Balazs
patent: 4582865 (1986-04-01), Balazs et al.
patent: 4808576 (1989-02-01), Schultz et al.
patent: 4937270 (1990-06-01), Hamilton et al.
patent: 5057503 (1991-10-01), Czop et al.
patent: 5080893 (1992-01-01), Goldberg et al.
patent: 5288503 (1994-02-01), Wood et al.
patent: 5506151 (1996-04-01), Ito et al.
patent: 5527893 (1996-06-01), Burns et al.
patent: 5679654 (1997-10-01), Tzianabos et al.
patent: 5700787 (1997-12-01), Tzianabos et al.
patent: 5760200 (1998-06-01), Miller et al.
patent: 5801170 (1998-09-01), Gaster et al.
patent: 5817643 (1998-10-01), Jamas et al.
patent: 5849794 (1998-12-01), Bianchi et al.
patent: 5965566 (1999-10-01), Greenwald et al.
patent: WO 95/09619 (1995-04-01), None
patent: WO 99/06354 (1999-02-01), None
Onderdonk, A.B. et al., “Anti-Infective Effect of Poly-β1-6-Glucotriosyl-β1-3-Glucopyranose Glucan In Vivo,”Infection and Immunity, 60(4):1642-1647 (1992).
Tzianabos, A.O. et al., “Protection Against Experimental Intraabdominal Sepsis by Two Polysaccharide Immunomodulators,”Journal of Infectious Diseases, 178:200-206 (1998).
Tzianabos, A.O. et al., “Polysaccharide-mediated Protection Against Abscess Formation in Experimental Intra-Abdominal Sepsis,”Journal of Clinical Investigation, 96(6):2727-2731 (1995).
Kuo, J.W. et al., “Chemical Modification of Hyaluronic Acid by Carbodiimides,”Bioconjugate Chem., 2:232-241 (1991).
Beuvery et al., Analytical, Toxicological and Immunological Consequences of hte Use of N-Ethyl-N'-(3-Dimethylaminopropyl) Carbodiimide as Coupling Reagent for the Preparation of Meningococcal Group C Polysaccharide-Tetanus Toxoid 1986.
Calias Pericles
Miller Robert J.
Onderdonk Andrew B.
Tzianabos Arthur O.
Badio Barbara P
Genzyme Corporation
Hamilton Brook Smith & Reynolds P.C.
The Brigham and Women's Hospital, Inc.
LandOfFree
Immunodulatory compositions and methods of use thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Immunodulatory compositions and methods of use thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Immunodulatory compositions and methods of use thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4034488